Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma [NA]
This clinical trial assesses the safety and efficacy of Pulsed Electric Field therapy for advanced or unresectable esophageal squamous cell …
-
CLINICAL_TRIALS other · 2025-01-01Clinical Trial Update: DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer [NA]
A clinical trial is evaluating DCE-MRI based on 4D free breathing to predict response to preoperative neoadjuvant chemoradiotherapy in esoph…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma [Phase 2]
A Phase 2 trial evaluating neoadjuvant chemoradiation with Camrelizumab and Nimotuzumab for initially inoperable esophageal cancer has compl…
-
CLINICAL_TRIALS research · 2024-12-30Clinical Trial Update: Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery [NA]
Clinical trial comparing paravertebral block vs epidural block for postoperative analgesia in esophageal surgery; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab [Phase 1]
Phase 1 trial evaluating dasatinib to prevent oxaliplatin-induced neuropathy in patients with metastatic gastrointestinal cancers receiving …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer [Phase 2]
A Phase 2 clinical trial investigating neoadjuvant comprehensive treatment for unresectable esophageal cancer; the study is currently recrui…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Oral AMXT 1501 Dicaprate in Combination With IV DFMO [Phase 1, Phase 2]
A Phase 1/2 trial of oral AMXT 1501 dicaprate in combination with IV DFMO has been terminated.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer [Phase 2]
A prospective Phase II randomized study evaluating chidamide in combination with camrelizumab and apatinib for advanced esophageal cancer; t…
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy [Phase 3]
A Phase 3 trial comparing proton therapy to photon therapy as part of trimodality treatment for esophageal cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Artificial Intelligence and Cancer Staging in Upper Gastrointestinal Malignancies
A clinical trial investigating artificial intelligence–assisted cancer staging in upper gastrointestinal malignancies has completed. The stu…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 dose-escalation study of JAB-3068, an SHP2 inhibitor, in adults with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 trial evaluating NC410 in combination with pembrolizumab for advanced unresectable or metastatic solid tumors across mul…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Chemoradiotherapy in Unresectable Esophageal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating chemoradiotherapy with nab-paclitaxel for unresectable esophageal cancer; the study is currently re…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
This clinical trial update reports on patient participation levels in lung cancer and esophageal cancer patients treated with definitive rad…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophageal Cancer After ESD Surgery [NA]
A clinical study investigates whether eradicating the oral bacterium Porphyromonas gingivalis can affect prognosis after endoscopic submucos…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Textbook Outcomes After Oesophagectomy in Regional Australia
This clinical trial evaluates textbook outcomes after oesophagectomy for esophageal cancer in regional Australia and is currently not yet re…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Total Intravenous Anesthesia and Recurrence Free Survival [Phase 3]
Phase 3 clinical trial evaluating total intravenous anesthesia and recurrence-free survival in esophageal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial of HS-20093 in patients with advanced esophageal cancer and other advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients with Oesophageal Cancer (VALUE)
This clinical trial update shows ongoing recruitment for NCT06440174, investigating variation in the use of modern endoscopic ultrasound in …
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis [Phase 2]
A Phase 2 study evaluating BO-112 in combination with pembrolizumab for colorectal and gastric/GEJ cancers with liver metastasis has been te…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Genetic and Environmental Risk Factors Related to Esophageal Cancer
Massachusetts General Hospital is conducting a clinical trial investigating genetic and environmental risk factors for esophageal cancer, cu…
-
CLINICAL_TRIALS other · 2024-11-21Clinical Trial Update: Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC [Phase 2]
Phase 2 trial evaluating camrelizumab plus apatinib mesylate and short-course chemotherapy for advanced esophageal cancer is currently recru…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
This clinical trial update shows that a rehabilitation and recovery program for persons with esophageal or gastric cancer is currently recru…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
This entry reports a recruiting clinical trial studying patient preferences for Barrett's esophagus and esophageal cancer screening tests.
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma [NA]
This clinical trial studies neoadjuvant chemoradiotherapy with hypofractionated radiotherapy for esophageal and gastroesophageal junction ad…